Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.05% |
| 2 | Technology | 7.69% |
| 3 | Financials | 6.83% |
| 4 | Healthcare | 6.42% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RXRAU
3526
DELISTED
RXR Acquisition Corp. Units
RXRAU
| $2.71M | ﹤0.01% |
274,630
-144,810
| -35% | -$1.44M |
|
|
BCEL
3527
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $2.69M | ﹤0.01% |
431,517
-23,046
| -5% | -$154K |
|
|
LGACU
3528
DELISTED
Lazard Growth Acquisition Corp. I Units
LGACU
| $2.69M | ﹤0.01% |
271,995
-973,544
| -78% | -$9.65M |
|
3529
Avient
AVNT
$4.1B
| $2.69M | ﹤0.01% |
57,958
+9,917
| +21% | +$476K |
|
3530
Fortuna Silver Mines
FSM
$3.63B
| $2.69M | ﹤0.01% |
683,543
+380,823
| +126% | +$1.7M |
|
3531
BorgWarner
BWA
$13.1B
| $2.68M | ﹤0.01% |
70,484
+16,997
| +32% | +$676K |
|
3532
BJ's Restaurants
BJRI
$1.39B
| $2.67M | ﹤0.01% |
64,050
-86,409
| -57% | -$3.63M |
|
3533
Katapult Holdings
KPLT
$483M
| $2.67M | ﹤0.01% |
19,690
+18,976
| +2,658% | +$3.3M |
|
3534
First Financial Bancorp
FFBC
$3.45B
| $2.67M | ﹤0.01% |
113,961
+54,911
| +93% | +$1.26M |
|
|
AVTA
3535
DELISTED
Avantax, Inc. Common Stock
AVTA
| $2.66M | ﹤0.01% |
170,704
-261,658
| -61% | -$4.23M |
|
3536
LiveRamp
RAMP
$2.29B
| $2.65M | ﹤0.01% |
56,190
-380,289
| -87% | -$17.2M |
|
3537
Viridian Therapeutics
VRDN
$2.61B
| $2.65M | ﹤0.01% |
161,345
+43,630
| +37% | +$640K |
|
|
ICBK
3538
DELISTED
County Bancorp, Inc. Common Stock
ICBK
| $2.65M | ﹤0.01% |
72,824
-7,203
| -9% | -$252K |
|
3539
Omeros
OMER
$1.35B
| $2.65M | ﹤0.01% |
192,242
-148,554
| -44% | -$2.22M |
|
3540
PUT
Progressive
PGR
$127B
| $2.65M | ﹤0.01% |
29,300
| – | – |
|
|
AMRS
3541
DELISTED
Amyris Inc.
AMRS
| $2.65M | ﹤0.01% |
192,770
-407,439
| -68% | -$5.83M |
|
3542
iShares Russell 2000 Value ETF
IWN
$14.5B
| $2.64M | ﹤0.01% |
+16,499
| New | +$2.65M |
|
3543
Mirum Pharmaceuticals
MIRM
$5.94B
| $2.64M | ﹤0.01% |
132,586
+87,615
| +195% | +$1.42M |
|
|
DHBC
3544
DELISTED
DHB Capital Corp. Class A common stock
DHBC
| $2.64M | ﹤0.01% |
272,271
| – | – |
|
3545
Ecovyst
ECVT
$1.11B
| $2.64M | ﹤0.01% |
226,378
+2,851
| +1% | +$38.9K |
|
3546
PUT
Zoetis
ZTS
$32B
| $2.64M | ﹤0.01% |
13,600
-61,400
| -82% | -$12.4M |
|
|
NIU
3547
Niu Technologies
NIU
$156M
| $2.64M | ﹤0.01% |
113,793
-134,424
| -54% | -$3.58M |
|
3548
iShares MSCI Peru and Global Exposure ETF
EPU
$568M
| $2.64M | ﹤0.01% |
100,000
+57,950
| +138% | +$1.57M |
|
|
GWB
3549
DELISTED
Great Western Bancorp, Inc.
GWB
| $2.63M | ﹤0.01% |
80,324
+55,097
| +218% | +$1.7M |
|
3550
First Business Financial Services
FBIZ
$593M
| $2.62M | ﹤0.01% |
91,333
-58,581
| -39% | -$1.62M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.
By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.